Akebia Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Akebia Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2024.
  • Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.65M, a 9.76% decline year-over-year.
  • Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $7.59M.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.32M, a 47.8% decline from 2022.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.8M, a 21.5% decline from 2021.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.7M, a 7.05% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.59M $1.65M -$178K -9.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.77M $2.07M -$1.42M -40.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.19M $2.36M -$129K -5.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.32M $1.51M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $1.82M -$1.53M -45.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.49M -$3.43M -49.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.49M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $3.36M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $6.92M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-28
Q1 2021 $25.5M $5.99M +$1.08M +21.9% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $24.5M $6.09M +$1.15M +23.4% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
Q3 2020 $23.3M $6.59M +$3.98M +152% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $19.3M $6.86M +$4.58M +201% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $14.7M $4.92M +$2.82M +135% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $11.9M $4.93M -$7.13M -59.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $19.1M $2.61M +$361K +16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $18.7M $2.28M -$210K -8.42% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $18.9M $2.09M -$138K -6.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $19M $12.1M +$9.87M +450% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $9.17M $2.25M +$99K +4.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $9.07M $2.49M -$11K -0.44% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $9.08M $2.23M -$3.2M -58.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $12.3M $2.19M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $2.15M +$525K +32.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.51M +$1.28M +105% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $5.43M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $1.63M +$466K +40.1% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.22M +$127K +11.6% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q4 2015 $4.71M $1.33M +$443K +50% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $4.27M $1.16M -$73K -5.91% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $4.34M $1.1M -$349K -24.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $4.69M $1.13M -$1.32M -53.9% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $6.01M $886K -$240K -21.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $6.25M $1.24M +$905K +274% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $5.35M $1.44M +$1.39M +2709% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $3.95M $2.45M +$2.39M +4236% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $1.56M $1.13M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $330K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $51.4K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $56.4K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.